The Case 41-year-old HIV patient with proteinuria and progressive renal dysfunction

Kidney International

Volumn 77, Issue 5, 2010, Pages 475-476

  Agarwala, Rajesh ^a   Mohan, Sumit ^a   Herlitz, Leal C ^a   Cheng, Jen Tse ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; ATENOLOL; CREATININE; EMTRICITABINE; ENALAPRIL; PHOSPHATE; RITONAVIR; TENOFOVIR; URIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CASE REPORT; CREATININE BLOOD LEVEL; FANCONI RENOTUBULAR SYNDROME; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MIXED INFECTION; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 76749148112     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.486     Document Type: Article

References (5)

1. Hassane I, Vincent LV, Corinne IB et al. Drug-induced Fanconi's syndrome. Am J Kid Dis 2003; 41: 292-309.
2. Zimmermann AE, Pizzoferrato T, Bedford J et al. Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Clin Infect Dis 2006; 42: 283-290.
3. Izzedine H, Hulot JS, Vittecoq D et al. Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrol Dial Transplant 2005; 20: 743-746.
4. Kohler JJ, Hosseini SH, Hoying-Brandt A et al. Tenofovir renal toxicity targets mitochondria of renal proximal tubules. Lab Invest 2009; 89: 513-519.
5. Rodŕiguez-Nóvoa S, Labarga P, Soriano V et al. Predictors of kidney tubular dysfunction in HIV infected patients treated with tenofovir: a pharmacogenetic study. Clin Infect Dis 2009; 48: e108-e116.